and a market that is expected to grow to $150 billion by 2030…Although GLP-1 drugs get a lot of buzz for their benefits, a large percentage – 50%-75% – of people who try the drugs stop using them within a year, due to side effects that can range from mild to severe… Among consumer goods companies, Conagra and Nestlé are trying to gain market share by marketing products to GLP-1 buyers. Read this article
